Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation (Q79327414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

pancreatic adenocarcinoma

21 December 2019

main subject

1 reference

6

Prajnan Das

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

James Lewis Abbruzzese

4

object named as

James L Abbruzzese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Sunil Krishnan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Vishal Rana

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Nora A Janjan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Morris S Gould

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Marc E Delclos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Shana Palla

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sushovan Guha

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gauri Varadhachary

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Douglas B Evans

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Robert A Wolff

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Christopher H Crane

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2589-2596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Current management of locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Pooling of Prognostic Studies in Cancer of the Pancreatic Head and Periampullary Region: the Triple-P Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Prognostic factors in the palliation of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Breast cancer trial with erythropoietin terminated unexpectedly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22328

7 January 2021

Identifiers

DOI

10.1002/CNCR.22328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083124%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference